2014-2015 / 2437
What to do?
On the evidence available:
•
no data to support the
superiority
of SRS over FSRT for
patients with pituitary tumours
•
Dose and fractionation should be chosen:
–
size
–
position of the pituitary adenoma
•
single-fraction SRS at doses of 16–25 Gy
small
pituitary
adenoma away from the optic chiasm
•
FSRT is preferred over SRS for lesions >2.5–3 cm in size
and/or involving the anterior optic pathway.
24/10/2017